In vitro fertilisation (IVF) is one of the major risk factors for an ectopic pregnancy (EP). Rates of EP in women undergoing IVF range from 2–5%…

One-third of the worldwide deaths relating to cardiovascular disease (CVD), such as heart attacks and strokes are due to the accompanying atherosclerotic…

The heart, unlike other organs, has a very limited capacity to repair which considerably contributes to heart disease being the most prevalent cause of…

Detailing some of the most important topics in haematology, EMJ Hematology 7.1 is now available.

Over the past year investigation into cell therapies has grown markedly, with an estimated 80% increase; the US and China are taking the lead in the development of these therapies, with Europe the closest behind.

Blastic plasmocytoid dendritic cell neoplasm (BPDCN), a rare, highly aggressive haematologic malignancy, often with cutaneous and other extramedullary…

EHA President Pieter Sonnevel welcomed the 12,614 haematology professionals to the Dutch capital, the largest number of attendees recorded…

Treatment of MM requires a multifaceted approach using a combination of therapies targeting the several pathophysiological pathways involved in the…

The authors report a prospective Phase II trial to assess (a) if post-transplant cyclophosphamide (PTCy) could be safely incorporated in a timed…